The data herein suggest that their expression alone does not blunt the development of CRC, indicating that the reduction in average tumor size seen in M(IL4)-treated mice is likely not dependent on arginase-1, FIZZ1 or Ym1. This evidence concerns the gene RETNLB and colorectal carcinoma.